Diurnal variations in angiostatin in human tear fluid: A possible role in prevention of corneal neovascularization

References

• Folkman, J. (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. iNature Medicine,i 1, 27–31.
   PubMed Web of Science ®Google Scholar
• O'Reilly, M. S., Holmgren, L., Shing, Y., Chen, C.,Rosenthal, R. A., Moses, M., Lane, W. S., Cao, Y., Sage, E. R., Folkman, J. (1994) Angiostatin: a novel angio-genesis inhibitor that mediates the suppression of me-tastases by a Lewis lung carcinoma. iCell,i b79,b 315–328.
   Google Scholar
• O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Va-sios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen,B. R., Folkman, J. (1997) Endostatin: an endogenous in-hibitor of angiogenesis and tumor growth. iCell,i b88,b 277–285.
   Google Scholar
• Cao, Y., Chen, A., An, S. S. A., Ji, R. W., Davidson,D., Llinas, M. (1997) Kringle 5 of plasminogen is a novel inhibitor of endothelial cell growth. iJ. Biol. Chem.i b272,b 22924–22928.
   Google Scholar
• Stathakis, P., Fitzgerald, M., Matthias, L. J., Chesterman,C. N., Hogg, P. J. (1997) Generation of angiostatin by reduction and proteolysis of plasmin. Catalysis by a plas-min reductase secreted by cultured cells. iJ. Biol. Chem.i b272,b 20641–20645.
   Google Scholar
• Gately, S., Twardowski, P., Stack, M. S., Cundiff, D.L., Grella, D., Castelllino, F. J, Enghild, J., Kwaan, H.C., Lee, F., Kramer, R. A., Volpert, 0., Bouck, N., Soff, G. A. (1997) The mechanism of cancer-mediated con-version of plasminogen to the angiogenesis inhibitor an-giostatin. iProc. Natl. Acad. Sci. USA.i b94,b 10868–10872.
   Google Scholar
• Dong, Z., Kumar, R., Yang, X., Fidler, IJ. (1997) Mac-rophage-derived metalloelastase is responsible for the gen-eration of angiostatin in Lewis lung carcinoma. iCell,i b88,b 801–810.
   Google Scholar
• Boehm, T., Folkman, J., Browder, T., O'Reilly, M. S. (1997) Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. iNature,i b390,b 404–407.
   Google Scholar
• Kenyon, B. M., Voest, E. E., Chen, C. C., Flynn, E., Flokman, J., D'Amato, R. J. (1996) A model of angio-genesis in the mouse cornea. iInv. Ophthal. Vis. Sci.i b37,b 1625–1632.
   Google Scholar
• Murata, M., Nakagawa, M. and Takahasi, M. (1997) In-hibitory effects of plasminogen fragment on experimen-tally induced neovascularization of rat corneas. iGraefes. Arch. Clin. Exp. Ophthmal.i b235,b 584–586.
   Web of Science ®Google Scholar
• Holden, B. A., Sweeney, D. F., Vannas, A., Nilsson, K. T., Efron, N. (1985) Effects of long-term extended con-tact lens wear on the human cornea. iInvest. Ophthmal. Vis. Sci.i b26,b 1489–1501.
   Web of Science ®Google Scholar
• Conners, M. S., Stoltz, R. A., Davis, K. L., Dunn, M. W., Abraham, N. G., Levere, R. D., Laniado-Schwartz-man, M. (1995) A closed eye contact lens model of cor-neal inflammation. Part 2: Inhibition of cytochrome P450 arachidonic acid metabolism alleviates inflammatory se-quelae. iInvest. Ophthal. Vis. Sci.i b36,b 841–850.
   Web of Science ®Google Scholar
• Husted, R. C., Conners, M. S., Stoltz, R. A., Dunn, M. W., Balazy, M., Laniado-Schwartzman, M. (1997) Quan-titative analysis of 12-hydroxy-5,8,14Eicosatrienoic acid (12-HETrE) in Rabbit aqueous humor and corneal ex-tracts and in human tears. iInvest. Ophthal. Vis. Sci.i b38b b(Suppl),b S285 Abstract.
   Google Scholar
• Thakur, A., Willcox, M. D., Stapleton, F. (1998) Theproinflammatory cytokines and arachidonic acid metab-olites in human overnight tears: homeostatic mechanisms.iJ. Clin. Immunol.i b18,b 61–70.
   Web of Science ®Google Scholar
• Imanaka, H., Taenaka, N., Nakamura, J., Aoyama, K., Hosotani, H. (1997) Ocular surface disorders in the crit-ically ill. iAnesth. Analg.i b85(2),b 343–346.
   Web of Science ®Google Scholar
• Sack, R. A.,Tan, K. 0., Tan, A. (1992) Diurnal tear cy-cle: evidence for a nocturnal inflammatory constitutive tear fluid. iInvest. Ophthal. Vis. Sci.i b33,b 626–640.
   Google Scholar
• Tan, K. 0., Sack, R. A., Holden, B. A., Swarbrick, H. A. (1993) Temporal sequence of changes in tear film com-position during sleep. iCurr. Eye. Res.i b12,b 1001–1007.
   Google Scholar
• Sack, R. A., Sathe, S., Hackworth, L. A., Willcox, M. D., Holden, B. A., Morris, C. A. (1996) The effect of eye closure on protein and complement deposition on Group IV hydrogel contact lenses: relationship to tear flow dynamics. iCurr. Eye. Res.i b15,b 1092–1100.
   Web of Science ®Google Scholar
• Willcox, M. D., Moris, C. A., Thakur, A., Sack, R. A., Wickson, J., Boey, W. (1997) Complement and comple-ment regulatory proteins in human tears. iInvest. Oph-thal. Vis. Sci.i b38,b 1–8.
   PubMed Web of Science ®Google Scholar
• Sack, R. A., Bogart, B. A., Beaton, A., Sathe, S., Lew, G. (1997) Diurnal variations in tear glycoproteins: evi-dence for an epithelial origin for the major non-reduc-ible or 450 kDa sialoglycoprotein(s). iCurr. Eye. Res.i b16,b 577–588.
   Web of Science ®Google Scholar
• Sakata, M., Sack, R. A., Sathe, S., Beaton, A. R. (1997) Polymorphonuclear leukocyte cells and elastase in tears. iCurr. Eye. Res.i b16,b 810–819.
   Web of Science ®Google Scholar
• Sack, R. A., Sathe, S., Beaton, A., Nunes, I. (1995) Tear proteases as a function of eye closure. iInvest. Ophthal. Vis. Sci.i b36(Suppl.),b S995Abstract.
   Google Scholar
• Sathe, S., Sakata, M., Beaton, A., Sack, R. A. (1998) Identification, origins and the diurnal role of the princi-pal serine protease inhibitors in human tear fluid. iCurr. Eye. Res.i b17,b 348–362.
   Web of Science ®Google Scholar
• Drew, A. F., Kaufman, A. H., Kombrinck, K. W., Dan-ton, M. J., Daugherty, C. C., Degen, J. L., Bugge, T. H. E. (1983) Ligneous conjunctivitis in plasminogen-defi-cient mice. iBlood.i b91,b 1616–1624.
   Google Scholar
• Kao, W. W., Kao, C. W., Kaufman, A. H., Kombrinck,K. W., Converse, R. L., Good, W. V., Gugge, T. H., Degen, J. L. (1983) Healing of corneal epithelial defects in plasminogen and fibrinogen-deficient mice. iInvest. Ophthal. Vis. Sci.i b39,b 502–508.
   Google Scholar
• Poon, R. Y., Toyoshima, H., Hunter, T. (1996) On the masking of signals on immunoblots by cellular proteins. iJ. Immunological Methods,i b199,b 155–158.
   Web of Science ®Google Scholar
• Huang, J. S., Huang, S. S., Deuel, T. F. (1984) Specific covalent binding of platelet-derived growth factor to human plasma a2-macroglobulin. iProc. Natl. Acad. Sci.USA.i b81,b 342–346.
   Web of Science ®Google Scholar
• Dennis, P. A., Saksela, 0., Harpel, P. and Rifkin, D. (1989) a2-Macroglobulin is a binding protein for basic fibroblast growth factor. iJ. Biol. Chem.i b264(13),b 7210–7216.
   Google Scholar
• Soker, S., Svahn, C. M. and Neufeld, G. (1993) Vascu-lar endothelial growth factor is inactivated by binding to a2-Macroglobulin and binding is inhibited by heparin. iJ. Biol. Chem.i b268(11),b 7685–7691.
   Web of Science ®Google Scholar
• Kurdowska, A., Can, F. K., Stevens, M. D., Baughman, R. P., Martin, T. R. (1997) Studies on the interaction of IL-8 with human plasma alpha 2-maroglobulin: evidence for the presence of IL-8 complexed to alpha 2-macro-globulin in lung fluids of patients with adult respiratory distress syndrome. iJ. of Immunol.i b158(4),b 1930–40.
   Web of Science ®Google Scholar
• Twining, S. S., Fukuchi, T., Yue, B. Y., Wilson, P. M., Zhou, X. (1994) Alpha 2-macroglobulin is present in and synthesized by the cornea. iInvest. Ophthal. Vis. Sci.i b35,b 3226–3233.
   Web of Science ®Google Scholar